BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

4.90
Delayed Data
As of Feb 21
 -0.16 / -3.16%
Today’s Change
3.95
Today|||52-Week Range
9.25
-0.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues9.0M9.4M3.1M8.8M
 
 
 
 
 
Cost of Goods Sold2.3M122.0K22.0K1.1M
 
 
 
 
 
Depreciation And Amortization172.0K172.0K172.0K178.0K
 
 
 
 
 
 
Operating ExpensesGross Income6.5M9.1M2.9M7.5M
 
 
 
 
 
General Expenses14.7M19.8M18.4M20.9M
 
 
 
 
 
Research And Development12.2M16.8M15.8M17.5M
 
 
 
 
 
Total Operating Expenses17.2M20.1M18.6M22.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.2M-10.7M-15.5M-13.3M
 
 
 
 
 
Extraordinary Credit5.7M0.00521.0K130.0K
 
 
 
 
Extraordinary Charge---1.5M0.000.00
 
 
Interest Expense On Debt2.1M2.1M2.1M2.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.5M-14.2M-16.9M-15.1M
 
 
 
 
 
Net Income-4.5M-14.2M-16.9M-15.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS73.8M75.2M80.4M83.6M
 
 
 
 
 
Shares To Calculate EPS Diluted73.8M75.2M80.4M83.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.19-$0.21-$0.18
 
 
 
 
 
EPS Diluted-$0.06-$0.19-$0.21-$0.18